NCT03432039 is a NA clinical trial of Psychoeducation in Malaria, sponsored by Makerere University.

Who is sponsoring NCT03432039?

NCT03432039 is sponsored by Makerere University.

What drugs are being tested in NCT03432039?

Interventions in NCT03432039: Psychoeducation, Behavioral.

Is NCT03432039 still recruiting?

NCT03432039 is currently completed. Last updated 4 September 2020.

Last reviewed 2020-09-04 · How we verify

NCT03432039

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preventing Mental Health Problems After Childhood Severe Malaria

Completed NA Last updated 4 September 2020

What this trial tests

NA trial testing Psychoeducation in Malaria in 120 participants. Completed in 31 July 2019.

Timeline

9 January 2018

Primary endpoint
31 July 2019

31 July 2019

Quick facts

Lead sponsor	Makerere University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	120
Start date	9 January 2018
Primary completion	31 July 2019
Estimated completion	31 July 2019
Sites	1 location across Uganda

Drugs / interventions tested

Psychoeducation
Behavioral

Conditions studied

Malaria — all drugs for Malaria →

Sponsor

Makerere University

Who can join

Adults 18 Months to 4, any sex, with Malaria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized trial in which caregivers of children suffering from malaria will be assigned to two treatment conditions to prevent mental health problems in the children. A psycho-education arm (control) and a behavioral arm (intervention). Pre- and post-intervention assessments for behavioral problems in the child and mother will be carried out.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Use of the creating opportunities for parent empowerment programme to decrease mental health problems in Ugandan children surviving severe malaria: a randomized controlled trial.
Bangirana P, Birabwa A, Nyakato M, Nakitende AJ, et al · · 2021 · cited 2× · PMID 34120616 · DOI 10.1186/s12936-021-03795-y
Use of the Creating Opportunities for Parent Empowerment Program to Decrease Mental Health Problems in Ugandan Children Surviving Severe Malaria: A Randomized Controlled Trial
Bangirana P, Birabwa A, Nyakato M, Nakitende AJ, et al · · 2020 · DOI 10.21203/rs.3.rs-75439/v1

Verify or expand the search:

Other trials of Psychoeducation

Trials testing the same drug.

NCT07227987 — Cognitive Rehabilitation for Treatment of Anger in Veterans With TBI and PTSD · NA · not yet recruiting
NCT06755827 — Pilot Testing a Novel Approach to Pediatric Obesity Treatment · Phase 1, PHASE2 · recruiting
NCT07129369 — Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program · NA · not yet recruiting
NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting
NCT06815692 — Interdisciplinary Interventions After mTBI · not yet recruiting

Other recruiting trials for Malaria

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07036159 — A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months · Phase 2 · recruiting
NCT06735209 — First-in-Human PfSPZ-LARC2 Vaccination/CHMI · Phase 1 · active not recruiting
NCT06854042 — A Study of Oral E1018 in Healthy Adult Participants · Phase 1 · recruiting
NCT06607003 — Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Cha · Phase 1 · recruiting

Other Makerere University trials

Trials by the same sponsor.

NCT07407868 — Call for Life Sepsis · NA · not yet recruiting
NCT06975670 — Enhancing Comprehension of Consent in Patients With Psychotic Disorders · NA · not yet recruiting
NCT06139198 — Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy. · NA · recruiting
NCT06791928 — Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services · Phase 2 · enrolling by invitation
NCT06563440 — Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-car · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03432039 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Makerere University
Last refreshed: 4 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03432039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing